A nurse is providing education to a client newly diagnosed with leukemia. The client asks, "Is leukemia a genetic condition?" How should the nurse respond?

A) This choice is incorrect because AML is not characterized by the overproduction of immature lymphocytes. It involves the uncontrolled proliferation of abnormal myeloid cells in the bone marrow.

B) This choice is incorrect because AML does not cause abnormal proliferation of red blood cells. Anemia may occur as a result of AML due to the displacement of normal blood-forming cells in the bone marrow.

C) This choice is correct. AML is a type of leukemia that arises from genetic mutations in the myeloid stem cells. These mutations lead to uncontrolled growth and accumulation of abnormal myeloid cells, including granulocytes, monocytes, and platelets.

D) This choice is incorrect because the abnormal growth of plasma cells leading to the production of abnormal antibodies is characteristic of multiple myeloma, not AML.

A) This choice is incorrect because the distinction between targeted therapy and chemotherapy is not based on whether the medications are derived from natural or synthetic sources.

B) This choice is correct. Targeted therapy is designed to selectively target leukemia cells, minimizing damage to healthy cells and reducing side effects compared to traditional chemotherapy, which affects both cancerous and healthy cells.

C) This choice is incorrect because the method of administration (hospitalization or outpatient) can vary for both targeted therapy and chemotherapy, depending on the specific drug and treatment plan.

D) This choice is incorrect because targeted therapy and chemotherapy are used in various stages of leukemia treatment, depending on the type and stage of the disease.